Psychiatry at Rhode Island Hospital

MIDAS Project

Publications

Following is a listing of published research and related abstracts. A listing of additional research that has been submitted for publication is also available. 

  1. Zimmerman, M., Mattia, J.I. Body dysmorphic disorder in psychiatric outpatients: Recognition, prevalence, comorbidity, demographic, and clinical correlates. Comprehensive Psychiatry, 1998, 39, 265-270.
    (abstract)

  2. Zimmerman, M., Mattia, J.I. Psychiatric diagnosis in clinical practice: Is comorbidity being missed? Comprehensive Psychiatry, 1999, 40, 182-191.
    (abstract)

  3. Zimmerman, M., Mattia, J.I. Is posttraumatic stress disorder underdiagnosed in routine clinical settings? Journal of Nervous and Mental Disease, 1999, 187, 420-428.
    (abstract)

  4. Zimmerman, M., Mattia, J.I. Psychotic subtyping of major depressive disorder and posttraumatic stress disorder. Journal of Clinical Psychiatry, 1999, 60, 311-314.
    (abstract)

  5. Zlotnick, C., Mattia, J.I., Zimmerman, M. Clinical correlates of self-mutilation in a sample of general psychiatric patients. Journal of Nervous and Mental Disease, 1999, 187, 296-301.
    (abstract)

  6. Zimmerman, M., Mattia, J.I. Axis I diagnostic comorbidity and borderline personality disorder. Comprehensive Psychiatry, 1999, 40, 245-252.
    (abstract)

  7. Zimmerman, M., Mattia, J.I. The reliability and validity of a screening questionnaire for 14 DSM-IV Axis I disorders (The Psychiatric Diagnostic Screening Questionnaire). Journal of Clinical Psychiatry, 1999, 60, 677-683.
    (abstract)

  8. Zimmerman, M., Mattia, J.I. Differences between clinical and research practice in diagnosing borderline personality disorder. American Journal of Psychiatry, 1999, 156, 1570-1574.
    (abstract)

  9. McDermut, W., Mattia, J.I. & Zimmerman, M. Comorbidity burden and its impact on psychosocial morbidity in depressed outpatients. Journal of Affective Disorders, 2001, 65, 289-295.
    (abstract)

  10. Zimmerman, M., McDermut, Wilson, Mattia, J.I. The frequency of anxiety disorders in psychiatric outpatients with major depressive disorder. American Journal of Psychiatry, 2000, 157, 1337-1400.
    (abstract)

  11. Zimmerman, M., Mattia, J.I. Principal and additional DSM-IV disorders for which outpatients seek treatment. Psychiatric Services, 2000, 51, 1299-1304.
    (abstract)

  12. Zimmerman, M., Mattia, J.I. The Psychiatric Diagnostic Screening Questionnaire: Development, reliability and validity. Comprehensive Psychiatry, 2001, 42, 175-189.
    (abstract)

  13. Posternak, M.A., Zimmerman, M. Switching versus augmentation: A prospective, naturalistic comparison in depressed, treatment-resistant patients. Journal of Clinical Psychiatry, 2001, 62, 135-142.
    (abstract)

  14. Zlotnick, C., Mattia, J.I., & Zimmerman, M. Clinical features of survivors of sexual abuse with major depression. International Journal of Child Abuse and Neglect, 2001, 25, 357-367.
    (abstract)

  15. Posternak, M.A., Zimmerman, M. Short-term spontaneous improvement rates in depressed outpatients. Journal of Nervous and Mental Disease, 2000, 188, 799-804.
    (abstract)

  16. Zimmerman, M., Mattia, J.I. A self-report scale to help make psychiatric diagnoses: The Psychiatric Diagnostic Screening Questionnaire (PDSQ). Archives of General Psychiatry, 2001, 58, 787-794.
    (abstract)

  17. Posternak, M.A., Zimmerman, M. The effectiveness of switching antidepressants during remission: A case series of depressed patients with intolerable side effects. Journal of Affective Disorders, 2002, 69, 237-240.
    (abstract)

  18. Zlotnick, C., Mattia, J.I., & Zimmerman, M. The relationship between posttraumatic stress disorder, childhood trauma and alexithymia in an outpatient sample. Journal of Traumatic Stress, 2001, 14, 177-188.
    (abstract)

  19. Zimmerman, M., Mattia, J.I. & Posternak, M.A. Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice. American Journal of Psychiatry, 2002, 159, 469-473.
    (abstract)

  20. Zlotnick, C., Zimmerman, M., Wolfsdorf, B.A., & Mattia, J.I. Gender differences in patients with posttraumatic stress disorder in a general psychiatric practice. American Journal of Psychiatry, 2001, 158, 1923-1925.
    (abstract)

  21. Posternak, M.A., Zimmerman, M. & Solomon, D.A. Integrating outcomes research into clinical practice: A pilot study. Psychiatric Services, 2002, 53, 335-336.
    (abstract)

  22. Posternak, M.A., Zimmerman, M. The validity of atypical depression. Archives of General Psychiatry, 2002, 59, 70-76.
    (abstract)

  23. Zimmerman, M. Breen, R.B., & Posternak, M.A. An open label study of citaloprim in the treatment of pathological gambling. Journal of Clinical Psychiatry, 2002, 63, 44-48.
    (abstract)

  24. Franklin, C.L., Zimmerman, M. Posttraumatic stress disorder and major depressive disorder: Investigating the role of overlapping symptoms in diagnostic comorbidity. Journal of Nervous and Mental Disease, 2001, 189, 548-551.
    (abstract)

  25. Posternak, M.A., Zimmerman, M. The symptoms of atypical depression. Psychiatry Research, 2002, 104, 175-181.
    (abstract)

  26. Posternak, M.A., Zimmerman, M. The prevalence of atypical features across mood, anxiety, and personality disorders. Comprehensive Psychiatry, 2002, 43, 253-262.
    (abstract)

  27. Posternak, M.A., Zimmerman, M., Miller, I., & Keitner, G. A reevaluation of the exclusion criteria used in antidepressant efficacy trials. American Journal of Psychiatry, 2002, 159, 191-200.
    (abstract)

  28. Rothschild, L., Zimmerman, M. Borderline personality disorder and age of onset in major depression. Journal of Personality Disorders, 2002, 16, 189-199.
    (abstract)

  29. Sheeran, T., Zimmerman, M. Screening for posttraumatic stress disorder in a general psychiatric outpatient setting. Journal of Consulting and Clinical Psychology, 2002, 70, 961-966.
    (abstract)

  30. Zimmerman, M., Chelminski, I., & McDermut, W. Major depressive disorder and Axis I diagnostic comorbidity. Journal of Clinical Psychiatry, 2002, 63, 187-193.
    (abstract)

  31. Zlotnick, C., Franklin, C.L., & Zimmerman, M. Does "subthreshold" posttraumatic stress disorder (PTSD) have any clinical relevance? Comprehensive Psychiatry, 2002, 43, 413-419.
    (abstract)

  32. Zlotnick, C., Franklin, C.L., & Zimmerman, M. Is comorbidity of posttraumatic stress disorder and borderline personality disorder related to greater pathology and impairment? American Journal of Psychiatry, 2002, 159, 1940-1943.
    (abstract)

  33. Sheeran, T., Zimmerman, M. Case identification of depression with self-report questionnaires. Psychiatry Research, 2002, 109, 51-59.
    (abstract)

  34. Posternak, M.A., Zimmerman, M. How accurate are patients in reporting their antidepressant treatment history? Journal of Affective Disorders, 2003, 75, 115-124.
    (abstract)

  35. Zimmerman, M., Posternak, M.A., & Chelminski, I. Symptom severity and exclusion from antidepressant efficacy trials. Journal of Clinical Psychopharmacology, 2002, 22, 610-614.
    (abstract)

  36. Posternak, M.A., Zimmerman, M. Anger and aggression in psychiatric outpatients. Journal of Clinical Psychiatry, 2002, 63, 665-672.
    (abstract)

  37. Rothschild, L., & Zimmerman, M. Personality disorders and the duration of depressive episode: A retrospective study. Journal of Personality Disorders, 2002, 16, 293-303.
    (abstract)

  38. Franklin, C. L., Posternak, M. A., & Zimmerman, M. The impact of subjective and expressed anger on the functioning of psychiatric outpatients with posttraumatic stress disorder. Journal of Interpersonal Violence, 2002, 17, 1263-1273.
    (abstract)

  39. Franklin, C. L., Young, D., & Zimmerman, M. Psychiatric patients' vulnerability in the wake of the September 11th terrorist attacks. The Journal of Nervous and Mental Disease, 2002, 190, 833-838.
    (abstract)

  40. Franklin, C.L., Sheeran,T., & Zimmerman, M. Screening for trauma history, posttraumatic stress disorder, and subthreshold PTSD in psychiatric outpatients. Psychological Assessment, 2002, 14, 467-471.
    (abstract)

  41. Breen, R.B. & Zimmerman, M. Rapid onset of pathological gambling in machine gambling. Journal of Gambling Studies, 2002, 18, 31-43.
    (abstract)

  42. Chelminski, I., Zimmerman, M. Pathological worry in depressed and anxious patients. Journal of Anxiety Disorders, 2003, 17, 1263-73.
    (abstract)

  43. McDermut, W., Zimmerman, M., & Chelminski, I. The construct validity of depressive personality disorder. Journal of Abnormal Psychology, 2003, 112, 49-60.
    (abstract)

  44. Posternak, M. & Zimmerman, M. Lack of association between seasonality and psychopathology in psychiatric outpatients. Psychiatry Research, 2002, 112, 187-194.
    (abstract)

  45. Sheeran, T. & Zimmerman, M. Social phobia: Still a neglected anxiety disorder? Journal of Nervous and Mental Disease, 2002, 190, 786-788.

  46. Zimmerman, M., Chelminski, I. Clinician recognition of anxiety disorders in depressed outpatients. Journal of Psychiatric Research, 2005, 191, 281-86.
    (abstract)

  47. Zimmerman, M., Sheeran, T., & Young, D. The Diagnostic Inventory for Depression: A self-report scale to diagnose DSM-IV Major Depressive Disorder. Journal of Clinical Psychology, 2004, 60, 87-110.
    (abstract)

  48. Zimmerman, M., Sheeran, T. Screening for principal versus comorbid conditions in psychiatric outpatients with the Psychiatric Diagnostic Screening Questionnaire (PDSQ). Psychological Assessment, 2003, 15, 110-114.
    (abstract)

  49. Zimmerman, M. & Chelminski, I. Generalized anxiety disorder in patients with major depressive disorder: Is DSM-IV's hierarchy correct? American Journal of Psychiatry, 2003, 160, 504-512.
    (abstract)

  50. Rothschild, L., Cleland, C., Haslam, N., & Zimmerman, M. A taxometric study of borderline personality disorder. Journal of Abnormal Psychology, 2003, 112, 657-66.
    (abstract)

  51. Zimmerman, M., Chelminski, I., & Posternak, M. An illustration of how a self-report diagnostic screening scale could improve the internal validity of antidepressant efficacy trials. Journal of Affective Disorders, 2004, 80, 79-85.
    (abstract)

  52. Zlotnick, C., Rothschild, L., & Zimmerman, M. The role of gender in the clinical presentation of patients with borderline personality disorder. Journal of Personality Disorders, 2002, 16, 277-282.
    (abstract)

  53. Zimmerman, M. What should the standard of care for psychiatric diagnostic evaluations be? Journal of Nervous and Mental Disease, 2003, 191, 281-286.
    (abstract)

  54. Posternak, M., Young, D., Sheeran, T., Chelminski, I., Franklin, C.L., & Zimmerman, M. The test-retest reliability of the Treatment Response to Antidepressant Questionnaire (TRAQ). Journal of Nervous and Mental Disease, 2004, 192, 95-102.
    (abstract)

  55. Zimmerman, M., Chelminski, I. & Posternak, M.A. Exclusion criteria used in antidepressant efficacy trials: Consistency across studies and representativeness of samples included. Journal of Nervous and Mental Disease, 2004, 192, 1091-3.

  56. Zimmerman, M., Posternak, M.A., Friedman, M, Attiullah, N., Baymiller, S., Boland, R., Berlowitz, S., Rahman, S., Uy, K., & Singer, S. Which factors influence psychiatrists' selection of an antidepressant? American Journal of Psychiatry, 2004, 161, 1285-89.
    (abstract)

  57. Zimmerman, M., Posternak, M.A., & Chelminski, I. Derivation of a definition of remission on the Montgomery-Asberg Depression Rating Scale corresponding to the definition of remission on the Hamilton Rating Scale for Depression. Journal of Psychiatry Research, 2004, 38, 577-582.
    (abstract)

  58. Zimmerman, M., Sheeran, T., Chelminski, I., & Young, D. Screening for psychiatric disorders in outpatients with DSM-IV substance use disorders. Journal of Substance Abuse Treatment, 2004, 26, 181-188.
    (abstract)

  59. Zimmerman, M., Posternak, M.A., Chelminski, I., & Solomon, D. Using questionnaires to screen for psychiatric disorders: A comment on a study of screening for bipolar disorder in the community. Journal of Clinical Psychiatry, 2004, 65, 605-610.

  60. Zimmerman, M., Chelminski, I. & Posternak, M.A. A review of studies of the Hamilton Depression Rating Scale in healthy controls: Implications for the definition of remission in treatment studies of depression. Journal of Nervous and Mental Disease, 2004, 35, 49-55.
    (abstract)

  61. Sheeran, T., Zimmerman, M. Factor analysis of the Psychiatric Diagnostic Screening Questionnaire. Journal of Behavior Therapy and Experimental Psychiatry, 2004, 35, 49-55.

  62. Zimmerman, M., Sheeran, T., Chelminski, I., & Young, D. Using a self-report depression scale to identify remission in depressed outpatients. American Journal of Psychiatry, 2004, 19, 215-220.

  63. Zimmerman, M., Rothschild, L. & Chelminski, I. The frequency of DSM-IV personality disorders in psychiatric outpatients. American Journal of Psychiatry, 2005, 162, 1991-1918.

  64. Zimmerman, M., Posternak, M.A., & Chelminski, I. Implications of using different cutoffs on symptom severity scales to define remission from depression. International Clinical Psychopharmacology, 2004, 19, 215-220.

  65. Zimmerman, M., Posternak, M.A., & Chelminski, I. Defining remission on the Montgomery-Asberg Depression Rating Scale. Journal of Clinical Psychiatry, 2004, 65, 163-168.

  66. Zimmerman, M., Posternak, M.A., & Chelminski, I. Is the cutoff to define remission on the Hamilton Rating Scale too high? Journal of Nervous and Mental Disease, 2005, 193, 170-175.

  67. Zimmerman, M., Chelminski, I., & Posternak, M.A. Derivation of cutoff scores on a self-administered depression scale corresponding to symptom severity exclusion thresholds on the Hamilton Depression Scale. Journal of Clinical Psychiatry, in press.

  68. Zimmerman, M., Chelminski, I., & Posternak, M.A. The generalizability of antidepressant efficacy trials: differences between depressed psychiatric outpatients who would and would not qualify for an efficacy trial. American Journal of Psychiatry, 2005, 162, 1370-1372.
    (abstract)

  69. Zimmerman, M., Posternak, M.A., Attiullah, N., Friedman, M., Boland, R., Baymiller, S., Berlowitz, S., Rahman, S., Uy, K., Singer, S., & Chelminski, I. Why isn't buporpion the most frequently prescribed antidepressant? Journal of Clinical Psychiatry, 2005, 66, 603-610.
    (abstract)

  70. Zimmerman, M., Chelminski, I., & Young, D. On the threshold of disorder: The impact of the DSM-IV clinical significance criterion on diagnosing depressive and anxiety disorders in clinical practice. Journal of Clinical Psychiatry, 2004, 65, 1400-1405.
    (abstract)

  71. Coccaro, E.F., Posternak, M.A., & Zimmerman, M. Prevalence and features of intermittent explosive disorder in a clinical setting. Journal of Clinical Psychiatry, 2005, 66, 1221-1227.

  72. Posternak, M. A., & Zimmerman. M. Elevated rates of psychosis among Hispanic patients with major depression. Journal of Nervous and Mental Disease, 2005, 193, 66-69.

  73. Posternak, M.A., & Zimmerman, M. Is there a delay in the antidepressant effect? A meta-analysis. Journal of Clinical Psychiatry, 2005, 66, 148-158.
    (abstract)

  74. Zimmerman, M., Posternak, M.A., Friedman, M. & Chelminski, I. A Standardized Clinical Outcome Rating Scale for Depression for use in clinical practice. Depression and Anxiety, 2005, 22, 36-40.
    (abstract)

  75. Zimmerman, M., Rothschild, L. & Chelminski, I. The prevalence of DSM-IV personality disorders in psychiatric outpatients. American Journal of Psychiatry, 2005, 162, 1911-1918.
    (abstract)

  76. Posternak, M. A., & Zimmerman, M. Dual reuptake inhibitors incur lower rates of tachyphylaxis than selective serotonin reuptake inhibitors: A retrospective study. Journal of Clinical Psychiatry, 2005, 66, 705-707.

  77. Zimmerman, M., Posternak, M., & Chelminski, I. Is it time to replace the Hamilton Depression Rating Scale as the primary outcome measure in treatment studies of depression? Journal of Clinical Psychopharmacology, 2005, 25, 105-110.
    (abstract)

  78. Zimmerman, M., Chelminski, I. Screening for anxiety disorders in depressed patients. Journal of Psychiatric Research, 2006; 40, 267-272.
    (abstract)

  79. Zimmerman, M., McGlinchey, J., Posternak, M., Friedman, M., Attiullah, N., & Boerescu, D. How should remission from depression be defined? The Depressed Patient’s Perspective. American Journal of Psychiatry, 2006, 163, 148-150.
    (abstract)

  80. Zimmerman, M., McGlinchey, J., Posternak, M., Friedman, M., Boerescu, D., & Attiullah N. Discordance Between Symptom Severity and Psychosocial Functioning Ratings in Depressed Outpatients: Implications for How Remission From Depression Should be Defined. Psychiatry Research, 2006, 141, 185-191.
    (abstract)

  81. Zimmerman, M., Chelminski, I. & Young, D. Prevalence and diagnostic correlates of DSM-IV pathological gambling in psychiatric outpatients. Journal of Gambling Studies, 2006, 22,  255-262.
    (abstract)

  82. Zimmerman, M. Pseudopatient or pseudoscience? A reviewer’s perspective. Journal of Nervous and Mental Disorders, 2005, 193, 740-742.

  83. Zimmerman, M., Posternak, M., McGlinchey, J., Friedman, M., Attiullah N. & Boerescu, D. Validity of a self-report depression symptom scale for identifying remission in depressed outpatients. Comprehensive Psychiatry, 2006, 47, 185-188.
    (abstract)

  84. Zimmerman, M., Posternak, M.A., Attiullah, N., Friedman, M, Boland, R., Baymiller, S., Berlowitz, S., Rahman, S., Uy, K., Singer, S., Chelminski, I., Thongy, T. Weight gain, sexual Dysfunctions, and bupropion. Journal of Clinical Psychiatry, 2005, 66, 1336-1339.

  85. Zimmerman, M., McGlinchey, J., Posternak, M., Friedman, M., Boerescu, D., & Attiullah N. Differences Between Minimally Depressed Patients Who Do and Do Not Consider Themselves To Be In Remission. Journal of Clinical Psychiatry, 2005, 66, 1134-1138.
    (abstract)

  86. Zimmerman, M., Chelminski, I. & Young, D. A psychometric evaluation of the DSM-IV pathological gambling diagnostic criteria. Journal of Gambling Studies, 2006, 22,  329-337.
    (abstract)

  87. Zimmerman, M., McGlinchey, J.B., Young, D., & Chelminski, I. Diagnosing Major Depressive Disorder: An examination of the DSM-IV diagnostic criteria. Journal of Nervous and Mental Disease, 2006, 194, 151-154.
    (abstract)

  88. Zimmerman, M., McGlinchey, J.B., Young, D., & Chelminski, I. Diagnosing Major Depressive Disorder: I. A psychometric examination of the DSM-IV symptom criteria. Journal of Nervous and Mental Disease, 2006, 194, 158-163.
    (abstract)

  89. Zimmerman, M., McGlinchey, J.B., Young, D., & Chelminski, I. Diagnosing Major Depressive Disorder: II. Is there justification for compound symptom criteria? Journal of Nervous and Mental Disease, 2006, 194, 235-240.
    (abstract)

  90. Zimmerman, M., McGlinchey, J.B., Young, D., & Chelminski, I. Diagnosing Major Depressive Disorder: III. Can some symptoms be eliminated from the diagnostic criteria? Journal of Nervous and Mental Disease, 2006, 194, 313-317.
    (abstract)

  91. Zimmerman, M., McGlinchey, J.B., Young, D., & Chelminski, I. Diagnosing Major Depressive Disorder: IV. Relationship between number of symptoms and the diagnosis of disorder. Journal of Nervous and Mental Disease, 2006, 194, 450-453.
    (abstract)

  92. Zimmerman, M., McGlinchey, J.B., Young, D., & Chelminski, I. Diagnosing Major Depressive Disorder: V. Applying the DSM-IV exclusion criteria in clinical practice. Journal of Nervous and Mental Disease, 2006, 194, 530-533.
    (abstract)

  93. Zimmerman, M., McGlinchey, J.B., Young, D., & Chelminski, I. Diagnosing Major Depressive Disorder: VI. Performance of an objective test as a diagnostic criterion. Journal of Nervous and Mental Disease, 2006, 194, 565-569.
    (abstract)

  94. Zimmerman, M., McGlinchey, J.B., Young, D., & Chelminski, I. Diagnosing Major Depressive Disorder: VII. Family history as a diagnostic criterion. Journal of Nervous and Mental Disease, 2006, 194, 704-707.
    (abstract)

  95. McGlinchey, J.B., Zimmerman, M., Young, D., & Chelminski, I. Diagnosing Major Depressive Disorder: VIII. Are some symptoms better than the current diagnostic criteria? Journal of Nervous and Mental Disease, 2006, 194, 785-790.
    (abstract)

  96. Zimmerman, M., McGlinchey, J.B., Young, D., & Chelminski, I. Diagnosing Major Depressive Disorder: IX. Are patients who deny low mood a distinct subgroup? Journal of Nervous and Mental Disease, 2006, 194, 864-869.
    (abstract)

  97. Zimmerman, M., McGlinchey, J.B., Young, D., & Chelminski, I. Diagnosing Major Depressive Disorder: X. Can the criteria be improved for use in medical settings? Journal of Nervous and Mental Disease, 2006, 194, 893-897.
    (abstract)

  98. Ruscio, J., Zimmerman, M., McGlinchey, J.B., Young, D., & Chelminski, I. Diagnosing Major Depressive Disorder: XI. A taxometric investigation of the categorical-dimensional debate on the structure underlying the DSM-IV symptoms. Journal of Nervous and Mental Disease, 2007, 195, 10-19.
    (abstract)

  99. Zimmerman, M., McGlinchey, J.B., Young, D., & Chelminski, I. Diagnosing Major Depressive Disorder: XII. Can a self-report scale be used to examine questions about the DSM-IV diagnostic criteria? Journal of Nervous and Mental Disease, 2007, 195, 158-154.
    (abstract)

  100. Rotenstein, O.H., McDermut, W., Zimmerman, M., & Chelminski, I. The validity of DSM-IV Passive-Aggressive (Negativistic) Personality Disorder. Journal of Personality Disorders, 2007, 21, 28-41.

  101. Zimmerman, M. & Chelminski, I. A scale to screen for axis I disorders in psychiatric outpatients:  Performance of the Psychiatric diagnostic Screening Questionnaire. Psychological Medicine, 2006, 36, 1601-1611.
    (abstract)

  102. Zimmerman, M., Ruggero, C., Chelminski, I., Young, D., Posternak, M., Friedman, M., Boerescu, D., & Attiullah, N.  Developing brief measures for use in clinical practice: The reliability and validity of single-item self-report measures of depression symptom severity, psychosocial impairment due to depression, and quality of life. Journal of Clinical Psychiatry, 2006, 67, 1536-1541.
    (abstract)

  103. Gibb, B. E., Chelminski, I., & Zimmerman, M. Childhood emotional, physical, and sexual abuse and diagnoses of depressive and anxiety disorders in adult psychiatric outpatients. Depression & Anxiety, 2007, 24, 256-263.
    (abstract)

  104. Gutman, J., McDermut, W., Miller, I., Chelminski, I., & Zimmerman, M. Personality pathology and its relation to  couple functioning. Journal of Clinical Psychology, 2006, 62, 1275-1289.
    (abstract)

  105. Huprich, S.K., Zimmerman, M., & Chelminski, I. Should self-defeating personality disorder be revisited in the DSM? Journal of Personality Disorders, 2006, 20, 388-400.
    (abstract)

  106. Huprich, S.K., Zimmerman, M., & Chelminski, I. Disentangling depressive personality disorder from avoidant, borderline, and obsessive-compulsive personality disorder. Comprehensive Psychiatry, 2006, 47, 298-306.
    (abstract)

  107. McGlinchey, J.B., Zimmerman, M. Posternak, M., Friedman, M., Attiullah, N. & Boerescu, D. The impact of gender, age, and depressed state on patients’ perspectives on remission. Journal of Affective Disorders, 2006, 95, 79-84.
    (abstract)

  108. First, M.B. & Zimmerman, M. Including laboratory tests in DSM-V diagnostic criteria. American Journal of Psychiatry, 2006, 163, 2041-2042.

  109. Dalrymple, K.L., & Zimmerman, M. Does secondary social anxiety disorder impact the clinical presentation of principal major depressive disorder? Journal of Affective Disorders, 2007, 100, 241-247.
    (abstract)

  110. Zimmerman, M., Posternak, M.A. & Ruggero, C.J. Impact of study design on the results of continuation studies of antidepressants. Journal of Clinical Psychopharmacology, 2007, 27, 177-181. 
    (abstract)

  111. Zimmerman, M., Posternak, M.A. & Chelminski, I. Heterogeneity among depressed outpatients considered to be in remission. Comprehensive Psychiatry, 2007, 48, 113-117.
    (abstract)

  112. Zimmerman, M. To screen or not to screen: Conceptual issues in screening for psychiatric disorders in psychiatric patients with a focus on the performance of the Psychiatric Diagnostic Screening Questionnaire. The International Journal of Mental Health & Addiction, in press. 

  113. Posternak, M., & Zimmerman, M. Therapeutic effect of follow-up assessments on antidepressant and placebo response rates in antidepressant efficacy trials: Meta-analysis. British Journal of Psychiatry, 2007, 190, 287-292.
    (abstract)

  114. Posternak, M., Novak, S., Stern, R., Hennessey, J., Joffe, R., Prange, A., & Zimmerman, M. A pilot effectiveness study: Placebo-controlled trial of adjunctive L-triiodothyronine (T3) used to accelerate and potentiate the antidepressant response. International Journal of Neuropsychopharmacology, 2007, 13, 1-11.
    (abstract)

  115. Ruggero, C.J., Chelminski, I., Young, D., & Zimmerman, M. Psychosocial impairment associated with bipolar II disorder. Journal of Affective Disorders, in press.

  116. Zimmerman, M, Francione-Witt, C, Chelminski, I, Young, D, Boerescu, D, Attiullah, N, Pohl, D, Roye, GD, Harrington, D Pre-surgical psychiatric evaluations of candidates for bariatric surgery: Part I. Reliability and reasons for exclusion. Journal of Clinical Psychiatry, 2007, 68, 1557-1562.
    (abstract)

  117. Zimmerman, M., & Thongy, T. How Often Do SSRIs and Other New Generation Antidepressants Lose Their Effect During Continuation Treatment?: Evidence Suggesting the Rate of True Tachyphylaxis During Continuation Treatment is Low. Journal of Clinical Psychiatry, 2007, 68, 1271-1276.
    (abstract)

  118. McGlinchey, J, & Zimmerman, M. Examining a dimensional representation of depression and anxiety disorders’ comorbidity in psychiatric outpatients with an item response modeling. Journal of Abnormal Psychology, 2007, 116, 464-474.
    (abstract)

  119. Zimmerman, M., McGlinchey, J.B., Young, D., & Chelminski, I. Diagnostic Comorbidity in 2,300 Psychiatric Outpatients Presenting for Treatment Evaluated with a Semi-Structured Diagnostic Interview. Psychological Medicine, 2008, 38, 199-210.
    (abstract)

  120. McGlinchey JB, Zimmerman M, Atkins DC. Clinical significance and remission in treating major depressive disorder: parallels between related outcome constructs. Harvard Review of Psychiatry, 2008, 16(1), 25-34.
    (abstract)

  121. Zimmerman M, Chelminski I, McGlinchey JB, Posternak MA. A clinically useful depression outcome scale. Comprehensive Psychiatry, 2008, Mar-Apr, 49(2), 131-40. Epub 2007 Dec 20.
    (abstract)

  122. Leventhal AM, Kahler CW, Ray LA, Zimmerman M. Refining the depression-nicotine dependence link: patterns of depressive symptoms in psychiatric outpatients with current, past, and no history of nicotine dependence. Addictive Behaviors, 2009, Mar, 34(3), 297-303. Epub 2008 Nov 21.
    (abstract)

  123. Novak SP, Herman-Stahl M, Flannery B, Zimmerman M. Physical pain, common psychiatric and substance use disorders, and the non-medical use of prescription analgesics in the United States. Drug and Alcohol Dependence, 2009, Feb 1, 100(1-2), 63-70. Epub 2008 Nov 17.
    (abstract)

  124. Mitchell AJ, McGlinchey JB, Young D, Chelminski I, Zimmerman M. Accuracy of specific symptoms in the diagnosis of major depressive disorder in psychiatric out-patients: data from the MIDAS project. Psychological Medicine, 2008, Nov 12, 1-10.
    (abstract)

  125. Dalrymple KL, Zimmerman M. Differences in clinical presentation between depressed outpatients wanting versus not wanting treatment for comorbid social anxiety disorder. Journal of Nervous and Mental Disease, 2008, Aug, 196(8), 639-42.
    (abstract)

  126. Leventhal AM, Francione Witt C, Zimmerman M. Associations between depression subtypes and substance use disorders. Psychiatry Research, 2008 Oct 30, 161(1), 43-50. Epub 2008 Sep 11.
    (abstract)

  127. Gaudiano BA, Dalrymple KL, Zimmerman M. Prevalence and clinical characteristics of psychotic versus nonpsychotic major depression in a general psychiatric outpatient clinic. Depression and Anxiety, 2008, Sep 9.
    (abstract)

  128. Gaudiano BA, Young D, Chelminski I, Zimmerman M. Depressive symptom profiles and severity patterns in outpatients with psychotic vs nonpsychotic major depression. Comprehensive Psychiatry, 2008, Sep-Oct, 49(5), 421-9. Epub 2008 Mar 28.
    (abstract)

  129. Zimmerman M, Chelminski I, Young D. The frequency of personality disorders in psychiatric patients. Psychiatric Clinics of North America, 2008, Sep, 31(3), 405-20, vi.
    (abstract)

  130. Zimmerman M, McGlinchey JB. Depressed patients' acceptability of the use of self-administered scales to measure outcome in clinical practice. Annals of Clinical Psychiatry, 2008, Jul-Sep, 20(3), 125-9.
    (abstract)

  131. Ray LA, Kahler CW, Young D, Chelminski I, Zimmerman M. The factor structure and severity of DSM-IV alcohol abuse and dependence symptoms in psychiatric outpatients. Journal of Studies on Alcohol and Drugs, 2008 Jul, 69(4), 496-9.
    (abstract)

  132. Dalrymple KL, Zimmerman M. Screening for social fears and social anxiety disorder in psychiatric outpatients. Comprehensive Psychiatry, 2008, Jul-Aug, 49(4), 399-406. Epub 2008 Mar 28.
    (abstract)

  133. Zimmerman M, Ruggero CJ, Chelminski I, Young D. Is bipolar disorder overdiagnosed? Journal of Clinical Psychiatry, 2008, Jun, 69(6), 935-40.
    (abstract)

  134. Ray LA, Miranda R Jr, Chelminski I, Young D, Zimmerman M. Diagnostic orphans for alcohol use disorders in a treatment-seeking psychiatric sample. Drug and Alcohol Dependence, 2008 Jul 1, 96(1-2), 187-91. Epub 2008 Apr 21.
    (abstract)

  135. Coryell W, Fiedorowicz J, Zimmerman M, Young E. HPA-axis hyperactivity and mortality in psychotic depressive disorder: preliminary findings. Psychoneuroendocrinology, 2008 Jun, 33(5), 654-8. Epub 2008 Apr 2.
    (abstract)

  136. Zimmerman M, Chelminski I, McGlinchey JB, Posternak MA. A clinically useful depression outcome scale. Comprehensive Psychiatry, 2008, Mar-Apr, 49(2), 131-40. Epub 2007 Dec 20.
    (abstract)

  137. Zimmerman M, McGlinchey JB, Chelminski I.  An Inadequate Standard of Care:  Lack of Measurement of Outcome When  Treating Depression in Clinical Practice. Primary Psychiatry, 2008, 15, 67-75.   

  138. Zimmerman, M, Francione-Witt, C, Chelminski, I, Young, D, Tortolani, C. Problems applying the DSM-IV eating disorders criteria in a general psychiatric outpatient practice. Journal of Clinical Psychiatry, 2008, 69, 381-384.

  139. Asnaani, A., Chelminski, I., Young, D., & Zimmerman, M.  Diagnosing borderline personality disorder: Does the number of criteria met make a difference? Journal of Personality Disorders, in press.

  140. Zimmerman, M., McGlinchey, J., Posternak, M., Friedman, M., Boerescu, D., & Attiullah N. Remission in depressed patients: More than just symptom resolution?  Journal of Psychiatric Research, 2007, 21, 615-625.

  141. Leventhal, A.M., Kahler, C.W., Ray, L.A., Stone, K., Young, D., Chelminski, I., & Zimmerman, M. Anhedonia and amotivation in psychiatric outpatients with fully remitted stimulant use disorder. American Journal on Addictions, in press.

  142. Zimmerman M, McGlinchey JB, Why Don’t Psychiatrists Use Scales to Measure Outcome When Treating Depressed Patients?  Journal of Clinical Psychiatry, in press.

  143. Zimmerman M, Ruggero CJ, Chelminski I, Young D., Psychiatric Diagnoses in Patients Previously Overdiagnosed With Bipolar Disorder.  Journal of Clinical Psychiatry, in press.

  144. Petersen T, Andreotti, CF, Chelminski I, Young D, Zimmerman M., Do Comorbid anxiety Disorders Impact Treatment Planning for Outpatients With Major Depressive Disorder? Psychiatry Research, in press.

  145. Ray LA, Capone C, Sheets E, Young D, Chelminski I, Zimmerman M., Posttraumatic Stress Disorder With and Without Alcohol Use Disorders: Diagnostic and Clinical Correlates in Psychiatric Outpatients. Psychiatry Research, in press

     

More research: Articles that have been submitted for publication

Back   |   More about MIDAS

 

Rhode Island Hospital  |  593 Eddy Street  |   Providence, RI  |  02903
©2009 Lifespan  |  Website Terms of Use  |  Patient Privacy Policy